DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Video Credit: ANI
Published on May 8, 2021 - Duration: 02:44s

DCGI approves DRDO's anti-COVID drug helpful in faster recovery

Drugs Controller General of India (DCGI) on May 08 approved emergency use DRDO's anti-COVID drug which the agency said will be helpful in faster recovery of hospitalised patients.

While speaking to ANI, Institute of Nuclear Medicine and Allied Sciences (INMAS-DRDO) scientists spoken about drug 2-deoxy-D-glucose (2-DG).

The drug will be of immense benefit to the people suffering from COVID-19.


You are here


💡 newsR Knowledge: Other News Mentions

COVID-19

Contagious disease caused by SARS-CoV-2
London Irish, Wasps and Worcester went out of business needing to repay more than £30m of Covid relief loans, a National Audit Office report says.
Credit: BBC Sport - Published 1 week ago


Related videos from verified sources

Covid-19: Rajnath Singh released first batch of anti-covid drug 2-DG | Oneindia News 02:34
Video credit: Oneindia - Published on May 17, 2021 

42% patients experience freedom from oxygen dependence: DRDO scientist on 2-DG clinical trials 01:59
Video credit: ANI - Published on May 9, 2021 

Covid update: Decongesting jails; DRDO's new oral drug; task force for oxygen 03:24
Video credit: HT Digital Content - Published on May 8, 2021 

You might like